Literature DB >> 11062367

Three-dimensional ultrasound analyses of the prostate.

E J Feleppa1, W R Fair, T Liu, A Kalisz, K C Balaji, C R Porter, H Tsai, V Reuter, W Gnadt, M J Miltner.   

Abstract

Although conventional ultrasonography has proven to be clinically useful for depicting many types of cancerous lesions, it cannot distinguish reliably between cancerous and noncancerous tissue of the prostate. Therefore, conventional transrectal ultrasonography (TRUS) is used primarily for general evaluations of the gland and for guiding biopsies based on clearly imaged anatomic features such as the capsule, seminal vesicles, and urethra. Spectrum analysis extracts ultrasound signal parameters associated with biopsy-proven tissue types, and these parameters are then classified using neural network tools such as learning vector quantization, radial basis, and multilayer perceptron algorithms. Classification of cancerous and noncancerous prostate tissue using neural networks produces receiver operating characteristic (ROC) curves of 0.87 +/- 0.04 compared with 0.64 +/- 0.04 for conventional ultrasonography. To image the prostate using these methods, parameter values are computed at each pixel location, then translated into a score for the likelihood of cancer using a look-up table generated using the best classification algorithm. The score for cancer likelihood is expressed as a gray-scale or color value, and the resulting image may be useful to guide biopsies or therapy. Changes in parameter or score values over time potentially can be used to assess progression of disease or efficacy of therapy.

Entities:  

Mesh:

Year:  2000        PMID: 11062367

Source DB:  PubMed          Journal:  Mol Urol        ISSN: 1091-5362


  13 in total

1.  [Transrectal ultrasound of the prostate. Current status and prospects].

Authors:  M Zacharias; K V Jenderka; H Heynemann; P Fornara
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

2.  Quantitative ultrasonic evaluation of radiation-induced late tissue toxicity: pilot study of breast cancer radiotherapy.

Authors:  Tian Liu; Jun Zhou; Emi J Yoshida; Shermian A Woodhouse; Peter B Schiff; Tony J C Wang; Zheng Feng Lu; Eliza Pile-Spellman; Pengpeng Zhang; Gerald J Kutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-19       Impact factor: 7.038

3.  Ultrasonic tissue characterization via 2-D spectrum analysis: theory and in vitro measurements.

Authors:  Tian Liu; Frederic L Lizzi; Jeffrey A Ketterling; Ronald H Silverman; Gerald J Kutcher
Journal:  Med Phys       Date:  2007-03       Impact factor: 4.071

4.  Estimation of Backscatter Coefficients Using an In Situ Calibration Source.

Authors:  Trong N Nguyen; Alex J Tam; Minh N Do; Michael L Oelze
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2019-09-27       Impact factor: 2.725

5.  How does performance of ultrasound tissue typing affect design of prostate IMRT dose-painting protocols?

Authors:  Pengpeng Zhang; K Sunshine Osterman; Tian Liu; Xiang Li; Jack Kessel; Leester Wu; Peter Schiff; Gerald J Kutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-01       Impact factor: 7.038

Review 6.  Review of Quantitative Ultrasound: Envelope Statistics and Backscatter Coefficient Imaging and Contributions to Diagnostic Ultrasound.

Authors:  Michael L Oelze; Jonathan Mamou
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2016-01-08       Impact factor: 2.725

7.  A feasibility study of novel ultrasonic tissue characterization for prostate-cancer diagnosis: 2D spectrum analysis of in vivo data with histology as gold standard.

Authors:  Tian Liu; Mahesh M Mansukhani; Mitchell C Benson; Ronald Ennis; Emi Yoshida; Peter B Schiff; Pengpeng Zhang; Jun Zhou; Gerald J Kutcher
Journal:  Med Phys       Date:  2009-08       Impact factor: 4.071

8.  Focal therapy, differential therapy, and radiation treatment for prostate cancer.

Authors:  Anudh K Jain; Ronald D Ennis
Journal:  Adv Urol       Date:  2012-05-16

9.  Quantitative ultrasound spectroscopic imaging for characterization of disease extent in prostate cancer patients.

Authors:  Ali Sadeghi-Naini; Ervis Sofroni; Naum Papanicolau; Omar Falou; Linda Sugar; Gerard Morton; Martin J Yaffe; Robert Nam; Alireza Sadeghian; Michael C Kolios; Hans T Chung; Gregory J Czarnota
Journal:  Transl Oncol       Date:  2015-02       Impact factor: 4.243

Review 10.  Focal low-dose rate brachytherapy for the treatment of prostate cancer.

Authors:  William Y Tong; Gilad Cohen; Yoshiya Yamada
Journal:  Cancer Manag Res       Date:  2013-09-13       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.